Catalyst Wire Dossier Catalyst Wire Dossier

Nucleoside drugs

nucleoside reverse transcriptase inhibitors
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Nucleoside drugs, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Assess the Effectiveness and Safety of Lipovirtide Combined With Nucleoside Drugs in HIV-infected Patients. [Phase 2]

See pricing